{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:13:54Z","timestamp":1787318034266,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jaad.2025.04.074","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T16:59:14Z","timestamp":1746723554000},"page":"749-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current and emerging therapies"],"prefix":"10.1016","volume":"93","author":[{"given":"Michael M.","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5913-9304","authenticated-orcid":false,"given":"Shari R.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1087-0024.2005.10102.x","article-title":"Prevalence of male and female pattern hair loss in Maryborough","volume":"10","author":"Gan","year":"2005","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2010.10011.x","article-title":"S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents","volume":"164","author":"Blume-Peytavi","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib3","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaad.2022.03.016","article-title":"A cross-sectional study of male balding patterns in people of color","volume":"87","author":"Yildirim","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.074_bib4","series-title":"StatPearls","article-title":"Androgenetic alopecia","author":"Ho","year":"2024"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.178536","article-title":"Classifications of patterned hair loss: a review","volume":"9","author":"Gupta","year":"2016","journal-title":"J Cutan Aesthet Surg"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.1977.tb15179.x","article-title":"Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex","volume":"97","author":"Ludwig","year":"1977","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0190-9622(03)00045-8","article-title":"The reliability of horizontally sectioned scalp biopsies in the diagnosis of chronic diffuse telogen hair loss in women","volume":"51","author":"Sinclair","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.04.074_bib8","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1346-8138.1998.tb02507.x","article-title":"Principles of hair cycle control","volume":"25","author":"Paus","year":"1998","journal-title":"J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","article-title":"Androgenetic alopecia: a review","volume":"57","author":"Lolli","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/ijdvl.IJDVL_262_17","article-title":"Genetic and molecular aspects of androgenetic alopecia","volume":"84","author":"Martinez-Jacobo","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1258\/acb.2012.012159","article-title":"Clinical biochemistry of dihydrotestosterone","volume":"50","author":"Marchetti","year":"2013","journal-title":"Ann Clin Biochem"},{"issue":"7","key":"10.1016\/j.jaad.2025.04.074_bib12","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3390\/genes14071326","article-title":"Female pattern hair loss: an overview with focus on the genetics","volume":"14","author":"Ho","year":"2023","journal-title":"Genes (Basel)"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaad.2004.04.008","article-title":"Evaluation and treatment of male and female pattern hair loss","volume":"52","author":"Olsen","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00403-017-1798-0","article-title":"5\u03b1-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss","volume":"310","author":"S\u00e1nchez","year":"2018","journal-title":"Arch Dermatol Res"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1523-1747.ep12335779","article-title":"Different levels of 5\u03b1-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia","volume":"109","author":"Sawaya","year":"1997","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1590\/abd1806-4841.20153370","article-title":"Female pattern hair loss: a clinical and pathophysiological review","volume":"90","author":"Ramos","year":"2015","journal-title":"Bras Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/tera.1420420111","article-title":"External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor","volume":"42","author":"Clark","year":"1990","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/(SICI)1096-9926(199702)55:2<119::AID-TERA1>3.0.CO;2-Z","article-title":"Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)","volume":"55","author":"Prahalada","year":"1997","journal-title":"Teratology"},{"key":"10.1016\/j.jaad.2025.04.074_bib19","series-title":"StatPearls","article-title":"Finasteride","author":"Zito","year":"2024"},{"issue":"8","key":"10.1016\/j.jaad.2025.04.074_bib20","first-page":"1121","article-title":"Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case\u2013control study","volume":"22","author":"Yao","year":"2011","journal-title":"Cancer Causes Control"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib21","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1067\/mjd.2000.107953","article-title":"Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia","volume":"43","author":"Price","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4103\/0974-7753.114709","article-title":"Finasteride 5 mg\/day treatment of patterned hair loss in normo-androgenetic postmenopausal women","volume":"5","author":"Oliveira-Soares","year":"2013","journal-title":"Int J Trichology"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","article-title":"5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss","volume":"25","author":"Yeon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archderm.142.3.298","article-title":"Finasteride treatment of female pattern hair loss","volume":"142","author":"Iorizzo","year":"2006","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib25","first-page":"414","article-title":"Side effects related to 5 \u03b1-reductase inhibitor treatment of hair loss in women: a review","volume":"15","author":"Seale","year":"2016","journal-title":"J Drugs Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2025.04.074_bib26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/ijd.14370","article-title":"The efficacy and use of finasteride in women: a systematic review","volume":"58","author":"Hu","year":"2019","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.074_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4103\/0378-6323.144162","article-title":"The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia","volume":"80","author":"Boersma","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2025.04.074_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/CCID.S398950","article-title":"The efficacy and safety of oral and topical spironolactone in androgenetic alopecia treatment: a systematic review","volume":"16","author":"Wang","year":"2023","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jocd.15979","article-title":"The efficacy of the combination of topical minoxidil and oral spironolactone compared with the combination of topical minoxidil and oral finasteride in women with androgenic alopecia, female and male hair loss patterns: a blinded randomized clinical trial","volume":"23","author":"Sadeghzadeh Bazargan","year":"2024","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaad.2020.03.087","article-title":"Spironolactone for treatment of female pattern hair loss","volume":"83","author":"Burns","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib31","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jaad.2020.10.097","article-title":"Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls","volume":"84","author":"Olamiju","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib32","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/bjd\/ljac068","article-title":"Retrospective analysis of the risk of hyperkalaemia in women older than 65 years of age prescribed spironolactone for female-pattern hair loss","volume":"188","author":"Collins","year":"2023","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib33","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1365-2133.2002.04798.x","article-title":"Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial","volume":"146","author":"Vexiau","year":"2002","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib34","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.det.2007.01.005","article-title":"Drug reactions affecting hair: diagnosis","volume":"25","author":"Tosti","year":"2007","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14740338.2023.2267978","article-title":"Characteristics of adverse drug reactions induced by flutamide and bicalutamide: a real-world pharmacovigilance study using FAERS","volume":"23","author":"Sun","year":"2024","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13096","article-title":"Oral bicalutamide for female pattern hair loss: a pilot study","volume":"32","author":"Fernandez-Nieto","year":"2019","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib37","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jaad.2025.01.056","article-title":"Combination of oral minoxidil and bicalutamide for the treatment of female pattern hair loss in adolescents","volume":"92","author":"Yoong","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib38","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaad.2020.03.034","article-title":"Safety of oral bicalutamide in female pattern hair loss: a retrospective review of 316 patients","volume":"83","author":"Ismail","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib39","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1210\/jc.2003-030330","article-title":"Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5\u03b1-reductase inhibitor","volume":"89","author":"Clark","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jaad.2025.04.074_bib40","series-title":"StatPearls","article-title":"Dutasteride","author":"Al-Horani","year":"2024"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jaad.2024.10.023","article-title":"5\u03b1-reductase inhibitor exposure for dermatologic conditions does not increase the risk of female breast or gynecologic cancers: a population-based propensity score-matched cohort study","volume":"92","author":"Chen","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.04.074_bib42","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ced.14340","article-title":"Spironolactone in dermatology: uses in acne and beyond","volume":"45","author":"Searle","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/pde.14391","article-title":"Use of spironolactone to treat acne in adolescent females","volume":"38","author":"Roberts","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.25259\/IJDVL_1280_2023","article-title":"Frequent potassium monitoring is associated with hyperkalemia that is clinically insignificant in females taking spironolactone for dermatologic conditions","volume":"90","author":"Hill","year":"2024","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaad.2024.01.057","article-title":"Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study","volume":"90","author":"Hill","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaad.2024.02.030","article-title":"No increased risk of breast or gynecologic malignancies in women exposed to spironolactone for dermatologic conditions: a retrospective cohort study","volume":"90","author":"Hill","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.074_bib47","author":"Devjani"},{"key":"10.1016\/j.jaad.2025.04.074_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s40257-020-00557-5","article-title":"Hormonal contraceptives and dermatology","volume":"22","author":"Williams","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.04.074_bib49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/CCID.S10182","article-title":"Alopecia: evaluation and treatment","volume":"4","author":"Gordon","year":"2011","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2025.04.074_bib50","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.JAA.0000541476.24116.c4","article-title":"Alopecia due to high androgen index contraceptives","volume":"31","author":"Graves","year":"2018","journal-title":"JAAPA"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib51","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1471-0528.2000.tb13228.x","article-title":"Length of use and symptoms associated with premature removal of the levonorgestrel intrauterine system: a nation-wide study of 17,360 users","volume":"107","author":"Backman","year":"2000","journal-title":"BJOG"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/humupd\/dmw016","article-title":"Hormonal contraceptives: pharmacology tailored to women's health","volume":"22","author":"De Leo","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.contraception.2010.04.002","article-title":"Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome","volume":"82","author":"De Leo","year":"2010","journal-title":"Contraception"},{"issue":"01","key":"10.1016\/j.jaad.2025.04.074_bib54","doi-asserted-by":"crossref","DOI":"10.4172\/2471-9323.1000105","article-title":"Hair restoration in androgenetic alopecia: looking beyond minoxidil, finasteride and hair transplantation","volume":"2","author":"Sonthalia","year":"2016","journal-title":"J Cosmetol Trichol"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib55","first-page":"195","article-title":"Influence of estrogens on the androgen metabolism in different subunits of human hair follicles","volume":"11","author":"Niiyama","year":"2001","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib56","first-page":"333","article-title":"Safety of oral contraceptives for teenagers","volume":"13","year":"1992","journal-title":"J Adolesc Health"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2025.04.074_bib57","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4274\/jcrpe.galenos.2019.2019.S0003","article-title":"Contraception for adolescents","volume":"12","author":"Todd","year":"2020","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.jaad.2025.04.074_bib58","series-title":"StatPearls","article-title":"Oral contraceptive pills","author":"Cooper","year":"2024"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/09546639709160517","article-title":"Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course","volume":"8","author":"Mazzarella","year":"1997","journal-title":"J Dermatol Treat"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40257-018-0387-0","article-title":"Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study","volume":"20","author":"Suchonwanit","year":"2019","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14678","article-title":"A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: clinical, histopathological, and physicochemical study","volume":"34","author":"Abdel-Raouf","year":"2021","journal-title":"Dermatol Ther"},{"issue":"11","key":"10.1016\/j.jaad.2025.04.074_bib62","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1111\/jocd.15328","article-title":"Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: a cross sectional-comparative study","volume":"21","author":"Ammar","year":"2022","journal-title":"J Cosmet Dermatol"},{"issue":"June","key":"10.1016\/j.jaad.2025.04.074_bib63","first-page":"1017","article-title":"Topical finasteride versus topical spironolactone in the treatment of androgenetic alopecia","volume":"88","author":"Ahmed","year":"2020","journal-title":"Med J Cairo Univ"},{"issue":"16","key":"10.1016\/j.jaad.2025.04.074_bib64","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s40265-020-01417-6","article-title":"Clascoterone: first approval","volume":"80","author":"Dhillon","year":"2020","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib65","article-title":"A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia","volume":"81","author":"Cartwright","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1610-0387.2007.06295.x","article-title":"Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women","volume":"5","author":"Blume-Peytavi","year":"2007","journal-title":"JDDG: J der Deutschen Dermatologischen Gesellschaft"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000250344","article-title":"[Local therapy of androgenetic alopecia with 17 alpha-estradiol. A controlled, randomized double-blind study (author's transl)]","volume":"161","author":"Orfanos","year":"1980","journal-title":"Dermatologica"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib69","first-page":"35","article-title":"Current therapies of female androgenetic alopecia and use of fluridil, a novel topical antiandrogen","volume":"79","author":"Hajd\u00fach","year":"2006","journal-title":"Scripta Med (Brno)"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib72","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41598-022-05544-w","article-title":"Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia","volume":"12","author":"Yun","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib73","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1468-3083.2012.04535.x","article-title":"Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation","volume":"27","author":"Moftah","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib74","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000518043","article-title":"Two cases of paradoxical nonscarring alopecia after mesotherapy with dutasteride","volume":"8","author":"Reguero Del Cura","year":"2022","journal-title":"Skin Appendage Disord"},{"issue":"2","key":"10.1016\/j.jaad.2025.04.074_bib75","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15247","article-title":"Frontal edema due to mesotherapy for androgenetic alopecia: a case series","volume":"35","author":"Melo","year":"2022","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/ijt.ijt_78_21","article-title":"Mesotherapy with bicalutamide: a new treatment for androgenetic alopecia","volume":"15","author":"Gomez-Zubiaur","year":"2023","journal-title":"Int J Trichology"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib78","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1345\/aph.1P600","article-title":"Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss","volume":"45","author":"Paradisi","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0015-0282(02)04551-X","article-title":"Treatment of hyperandrogenic alopecia in women","volume":"79","author":"Carmina","year":"2003","journal-title":"Fertil Steril"},{"issue":"7","key":"10.1016\/j.jaad.2025.04.074_bib80","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women","volume":"20","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Hum Reprod"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.21608\/smj.2018.42083","article-title":"Topical dutasteride with microneedling in treatment of male androgenetic alopecia","volume":"22","author":"Nada","year":"2018","journal-title":"Sohag Med J"},{"issue":"10","key":"10.1016\/j.jaad.2025.04.074_bib82","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1111\/jdv.18285","article-title":"Microneedling plus topical dutasteride solution for androgenetic alopecia: a randomized placebo-controlled study","volume":"36","author":"S\u00e1nchez-Meza","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2025.04.074_bib83","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1159\/000017954","article-title":"Ketoconazole shampoo: effect of long-term use in androgenic alopecia","volume":"196","author":"Pi\u00e9rard-Franchimont","year":"1998","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.jaad.2025.04.074_bib84","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1346-8138.2002.tb00314.x","article-title":"Comparative efficacy of various treatment regimens for androgenetic alopecia in men","volume":"29","author":"Khandpur","year":"2002","journal-title":"J Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2025.04.074_bib85","article-title":"Strategies for the discovery of oral PROTAC degraders aimed at cancer therapy","volume":"3","author":"Han","year":"2022","journal-title":"Cell Rep Phys Sci"},{"key":"10.1016\/j.jaad.2025.04.074_bib86","author":"Rani"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0960-0760(94)90250-X","article-title":"RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism","volume":"48","author":"Battmann","year":"1994","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.074_bib88","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1365-2133.1997.19382053.x","article-title":"A controlled study of the effects of RU58841, a non-steroidal antiandrogen, on human hair production by balding scalp grafts maintained on testosterone-conditioned nude mice","volume":"137","author":"De Brouwer","year":"1997","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/1027-8117.357357","article-title":"Comorbid laboratory abnormalities in female pattern hair loss patients","volume":"40","author":"Wang","year":"2022","journal-title":"Dermatologica Sinica"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib91","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mcna.2021.06.008","article-title":"Practical approach to hyperandrogenism in women","volume":"105","author":"Sharma","year":"2021","journal-title":"The Med Clin North America"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.074_bib92","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jaad.2024.09.028","article-title":"Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: a single-center retrospective cohort study","volume":"92","author":"Venkatesh","year":"2025","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.074_bib93","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14234","article-title":"Efficacy and safety of oral minoxidil in female androgenetic alopecia","volume":"33","author":"Vastarella","year":"2020","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2025.04.074_bib94","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40257-022-00691-2","article-title":"Lessons learned from orthopedics: a call to action for more rigorous platelet-rich plasma hair loss clinical trials","volume":"23","author":"Lipner","year":"2022","journal-title":"Am J Clin Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225007224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225007224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:09:15Z","timestamp":1755648555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225007224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":89,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0190962225007224"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.04.074","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current and emerging therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.04.074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}